Achieving Drug Discovery Success with Inotiv’s Comprehensive Approach

Navigating drug candidates while mitigating downstream risk through drug discovery requires the right level of experience to enable confirmation of favorable characteristics and identification of unfavorable attributes early on in discovery phases.

Inotiv’s team of industry experienced scientists harness the importance of these areas needed to progress your therapy through the foundational discovery stages of drug development. We offer drug discovery expertise coupled with a comprehensive array of in vitro and in vivo study designs and execution including disease pharmacology, drug metabolism and pharmacokinetics (DMPK), drug to drug interaction (DDI), metabolite ID, disease biomarker development, cell and molecular biology, investigative toxicology, and histopathology. Supported by Inotiv’s wealth of pharmaceutical experience and collaborative approach, you can be confident in partnering with Inotiv to make timely data-driven go/no-go decisions with your studies.